Improvements to the APBS biomolecular solvation software suite E Jurrus, D Engel, K Star, K Monson, J Brandi, LE Felberg, DH Brookes, ... Protein Science 27 (1), 112-128, 2018 | 1623 | 2018 |
Omicron variant (B. 1.1. 529): infectivity, vaccine breakthrough, and antibody resistance J Chen, R Wang, NB Gilby, GW Wei Journal of chemical information and modeling 62 (2), 412-422, 2022 | 736 | 2022 |
Mutations strengthened SARS-CoV-2 infectivity J Chen, R Wang, M Wang, GW Wei Journal of molecular biology 432 (19), 5212-5226, 2020 | 477 | 2020 |
Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants R Wang, J Chen, K Gao, Y Hozumi, C Yin, GW Wei Communications biology 4 (1), 228, 2021 | 227* | 2021 |
Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries R Wang, J Chen, K Gao, GW Wei Genomics 113 (4), 2158-2170, 2021 | 184 | 2021 |
Omicron BA. 2 (B. 1.1. 529.2): high potential for becoming the next dominant variant J Chen, GW Wei The journal of physical chemistry letters 13 (17), 3840-3849, 2022 | 157* | 2022 |
Repositioning of 8565 existing drugs for COVID-19 K Gao, DD Nguyen, J Chen, R Wang, GW Wei The journal of physical chemistry letters 11 (13), 5373-5382, 2020 | 154* | 2020 |
Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies J Chen, K Gao, R Wang, GW Wei Chemical science 12 (20), 6929-6948, 2021 | 101 | 2021 |
Mechanisms of SARS-CoV-2 evolution revealing vaccine-resistant mutations in Europe and America R Wang, J Chen, GW Wei The journal of physical chemistry letters 12 (49), 11850-11857, 2021 | 97 | 2021 |
Decoding asymptomatic COVID-19 infection and transmission R Wang, J Chen, Y Hozumi, C Yin, GW Wei The journal of physical chemistry letters 11 (23), 10007-10015, 2020 | 81 | 2020 |
Emerging vaccine-breakthrough SARS-CoV-2 variants R Wang, J Chen, Y Hozumi, C Yin, GW Wei ACS infectious diseases 8 (3), 546-556, 2022 | 80 | 2022 |
Revealing the threat of emerging SARS-CoV-2 mutations to antibody therapies J Chen, K Gao, R Wang, GW Wei Journal of molecular biology 433 (18), 167155, 2021 | 74 | 2021 |
Unveiling the molecular mechanism of SARS-CoV-2 main protease inhibition from 137 crystal structures using algebraic topology and deep learning DD Nguyen, K Gao, J Chen, R Wang, GW Wei Chemical science 11 (44), 12036-12046, 2020 | 70 | 2020 |
Perspectives on SARS-CoV-2 main protease inhibitors K Gao, R Wang, J Chen, JJ Tepe, F Huang, GW Wei Journal of medicinal chemistry 64 (23), 16922-16955, 2021 | 66 | 2021 |
Methodology-centered review of molecular modeling, simulation, and prediction of SARS-CoV-2 K Gao, R Wang, J Chen, L Cheng, J Frishcosy, Y Huzumi, Y Qiu, ... Chemical Reviews 122 (13), 11287-11368, 2022 | 53 | 2022 |
Evolutionary de rham-hodge method J Chen, R Zhao, Y Tong, GW Wei Discrete and continuous dynamical systems. Series B 26 (7), 3785, 2021 | 49 | 2021 |
Persistent Laplacian projected Omicron BA. 4 and BA. 5 to become new dominating variants J Chen, Y Qiu, R Wang, GW Wei Computers in Biology and Medicine 151, 106262, 2022 | 48 | 2022 |
Review of COVID-19 antibody therapies J Chen, K Gao, R Wang, DD Nguyen, GW Wei Annual review of biophysics 50 (1), 1-30, 2021 | 40 | 2021 |
HERMES: Persistent spectral graph software R Wang, R Zhao, E Ribando-Gros, J Chen, Y Tong, GW Wei Foundations of data science (Springfield, Mo.) 3 (1), 67, 2021 | 32 | 2021 |
The de Rham–Hodge analysis and modeling of biomolecules R Zhao, M Wang, J Chen, Y Tong, GW Wei Bulletin of mathematical biology 82, 1-38, 2020 | 23 | 2020 |